Integrity and Innovations
Since our founding in 1921, Cleveland Clinic has been a leading medical innovator. The organization's discoveries have saved millions of patients’ lives, and many are standard practice in medicine today.
Industry collaborations with medical schools, hospitals and biomedical research institutions are critical to furthering research efforts and accelerating innovative patient care.
Furthering Patient Care
Biotechnology companies require physician investigators and patient participants in clinical trials to gain government approval of new products. Even before a product is ready for a clinical trial, development of breakthrough medicines and new medical procedures requires participation and input from practicing physicians and experienced scientific researchers.
Cleveland Clinic believes that medical innovation significantly benefits patient care. At the same time, they recognize that innovation must be managed with extraordinary sensitivity and transparency. We are fully
Protection for Patients Enrolled in Clinical Trials
All research involving human subjects at Cleveland Clinic is submitted to Cleveland Clinic’s Institutional Review Board (IRB), a committee of physicians, ethicists, statisticians, community advocates and others whose objective is to ensure that a clinical trial is ethical and the rights of study participants are protected.